Cite
HARVARD Citation
Gonzalez‐Ericsson, P. et al. (2020). The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice. Journal of pathology. 250 (5), pp. 667-684. [Online].